#Imagine if Europe found the treatment to slow Alzheimer’s progression, produced the first vaccine for brain cancer or medicines that could transform the lives of patients with chronic disease. Now we've imagined. Let's take action: https://shorturl.at/cCGVZ #WeWontRest
EFPIA - European Federation of Pharmaceutical Industries and Associations
Pharmaceutical Manufacturing
Illness never sleeps, so neither can we #WeWontRest
About us
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 41 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world. Twitter : @EFPIA Website : www.efpia.eu
- Website
-
http://www.efpia.eu
External link for EFPIA - European Federation of Pharmaceutical Industries and Associations
- Industry
- Pharmaceutical Manufacturing
- Company size
- 11-50 employees
- Type
- Nonprofit
- Founded
- 1978
- Specialties
- Pharmaceutical Industry
Locations
-
Primary
-
Rue de Trône 108,
Brussels, 1050, BE
Employees at EFPIA - European Federation of Pharmaceutical Industries and Associations
-
Sofia Hamirally, PhD, PMP
-
Kristine Peers
-
Hans-Chr. Holten Lützhøft
Pharmaceuticals in the Environment. Environmental Risk Assessment. Manufacturing effluents management. Supplier audits.
-
Dr. Anirban Sadhu
Vice President, Global Regulatory Affairs; Board Member; Drug Development; Art Collector; Writer & Author; Public Speaker
Updates
-
EFPIA - European Federation of Pharmaceutical Industries and Associations reposted this
📢 Are you a patient who has experienced Antimicrobial Resistance (AMR)? As part of the European Antibiotic Awareness Day on 18 November 2024, EPF is collaborating with the European Centre for Disease Prevention and Control (ECDC) and Health First Europe to launch a new series of patient stories highlighting the critical issue of #AMR. These real-life stories aim to broaden public knowledge about AMR and illustrate the impacts on individuals’ lives, their families and the society. ✍ Share your patient story in English or in your mother tongue by 13 September 2024. Read more details here 👉 https://bit.ly/3zZlaJu #PatientAdvocacy #AntimicrobialResistance #AMRsurvivors #antibiotics #patients
-
-
EFPIA - European Federation of Pharmaceutical Industries and Associations reposted this
Europe remains a leading source of new medicines and vaccines globally🌎, but the region has been losing ground against its main competitors. 🔴Twenty years ago, the amount of investment made by #pharma companies in R&D in the US and Europe differed by only €2 billion. By 2020, this investment in the US exceeded the amount spent in Europe by almost €25 billion. Europe can regain its global leadership, provided that we continue to invest in science and healthcare and maintain a competitive incentive framework. Uncover this and other insights on the #pharma innovation process in the MSD #PolicyPassport: https://lnkd.in/e4_WjKw6
-
-
Health research collaborations mean sharing data – we can deliver faster if we identify and remove obstacles early. Capturing the experience of scientists who have travelled this road, IHI and EFPIA have put together a #Data #Sharing #Playbook. It offers practical solutions to common data sharing challenges, enabling researchers to focus on what matters most – advancing medical science. Explore the Playbook and join us on 4 September for a masterclass on how to facilitate data sharing ➡ https://bit.ly/46hVGmp #IHITransformingHealth #WeWontRest
-
EFPIA - European Federation of Pharmaceutical Industries and Associations reposted this
📢 We’re excited to announce the launch of our first research Call! Submit your proposals to leverage #biosamples & data catalogued on the EPND Platform. Join a growing community of researchers working to change the future of #neurodegenerative diseases. Successful applicants can receive financial support and will benefit from an array of resources and services, including facilitated access to #neurodegeneration biosamples and #datasets. Read more and apply! ➡ https://lnkd.in/ednEcEUz Looking for potential collaborators, biosamples and datasets? Discover >70 #neurodegeneration studies across 12 disease areas in the EPND Catalogue, representing more than 240,000 research participants. Explore the Catalogue ➡ https://lnkd.in/eGcTnUyt Want to learn more about the application procedure, research requirements and important deadlines for our Call? Read our guidance and FAQs ➡ https://lnkd.in/e9VsrxBm Ready to apply? Download and complete the short application form, and submit to [email protected] by 15 September, 2024. Download the application form ➡ https://lnkd.in/ef2qeBj3 EPND is creating new pathways for collaborative research. Together, we can change the future of #neurodegenerative diseases 🌟 Innovative Health Initiative (IHI) EFPIA - European Federation of Pharmaceutical Industries and Associations Maastricht University University of Leicester Gates Ventures UCB AC Immune Alzheimer Europe Amsterdam UMC Aridhia – Digital Research Environment – DRE BBMRI-ERIC BMD Software Regulatory Science CBG-MEB German Center for Neurodegenerative Diseases (DZNE) IBBL (Integrated BioBank of Luxembourg) The Janssen Pharmaceutical Companies of Johnson & Johnson King's College London CHUV | Lausanne university hospital Lygature Novartis Roche Sanofi Svar Life Science AB SYNAPSE Research Management PartnersTakeda Teva Pharmaceuticals University of Oxford University of Geneva University of Gothenburg University of Luxembourg
-
EFPIA - European Federation of Pharmaceutical Industries and Associations reposted this
Director Science Policy at EFPIA - European Federation of Pharmaceutical Industries and Associations
Numbers of animals used for scientific purposes in the EU are on the decline!!!! And this is clearly evident with a 50 % decrease for animals used for regulatory purposes in medical procedures!! The European Commission has published their report on the statistics on the use of animals for scientific purposes in the Member States of the European Union and Norway in 2022 and the second EU Implementation Report of Directive 2010/63 on the protection of animals used for scientific purposes. The 6th report of data reported in 2022 on the use of animals for scientific purposes demonstrates clear positive impacts of the 3Rs and animal welfare particularly in the use of animals for regulatory purposes. In 2022, uses for regulatory procedures continued to decrease significantly with -16.2% compared to 2021 and -32% compared to 2018, which represents more than half a million uses of animals for this purpose – a trend that started already in 2015. This decrease is mainly due to continuous reductions in uses related to legislations on medicinal products for human use (-50.2% representing 519,088 less uses compared to 2018). Regulatory use purposes where alternative methods are or have become available that saw significant decreases over the past five years are: batch potency testing (-39.9% representing 300,259 less uses), batch safety testing (-40.6% representing 55,813 less uses), safety testing in food and feed area (-73.9% representing 30,433 less uses), pyrogenicity testing (-35.7% representing 10,647 less uses) and skin irritation/corrosion (-30.1% representing 1,205 less uses). Looking at overall numbers, the total number of animals used for the first time in 2022 decreased back to 8.39 million (-10.9% compared to 2021) confirming the exceptional nature of the increase reported in 2021 and a longer-term decreasing trend (-5% compared to 2018). The data presented in this report can be consulted at both Union and Member State level using the open access public ALURES Statistical EU database . https://lnkd.in/eRe3Cb92 https://lnkd.in/eWf73tma #3Rs #animalwelfare #medicines
-
EFPIA - European Federation of Pharmaceutical Industries and Associations reposted this
As the first European Parliament Plenary of the new mandate gets underway, we are delighted to see so many returning MEPs who supported our EACH Summit in Strasbourg last year! In case you missed it, see a snapshot below of some of the 100 MEPs who joined the call for better #CardiovascularHealth in Europe. A big welcome to all the newly elected officials and welcome back to others such as MEPs Dolors Montserrat, Tomislav Sokol, Elzbieta Łukacijewska, Barry Andrews MEP, Brando Benifei, ALESSANDRA MORETTI, Nicolás González Casares, Magdalena Adamowicz, Mohammed Chahim, Lukas MANDL, Maria Walsh, Tilly Metz, Ondrej Knotek, Billy Kelleher MEP, Susana Solís Pérez and many more! This is the moment for action on CVD, we look forward to working with you! #CVHealth4All 💗 Read more: https://lnkd.in/eFZdqU5m Our EACH Partners: European Society of Cardiology EFPIA - European Federation of Pharmaceutical Industries and Associations COCIR European Atherosclerosis Society European Chronic Disease Alliance ECHDO European Heart Network (EHN) EKHA - European Kidney Health Alliance ERC European Resuscitation Council European Stroke Organisation European Society for Vascular Surgery EUCOPE - European Confederation of Pharmaceutical Entrepreneurs European Institute of Women's Health, CLG ESH European Society of Hypertension European Thrombosis and Haemostasis Alliance FH Europe Foundation MedTech Europe Global Heart Hub Stroke Alliance For Europe (SAFE) World Heart Federation
-
Europe's regulatory system can be a brake or an accelerator in bringing new treatments to patients. IHI Call 8 aims to future-proof the EU regulatory framework by designing and facilitating the efficient implementation of #regulatory #sandboxes. Check out the call text and find out how you can help bring innovation to patients faster. Deadline is 10 October 2024! Learn more here: https://bit.ly/3zOOYs9 #WeWontRest #IHITransformingHealth
-
-
EFPIA - European Federation of Pharmaceutical Industries and Associations reposted this
An EU #CardiovascularHealth Plan is urgently needed to save lives, improve patient outcomes, and safeguard our workforce and economies. The status quo of CVD as the number one killer in Europe cannot be left unchallenged. Following the re-election this afternoon of Ursula von der Leyen as European Commission President for a second term, we are encouraged to see the commitment to focus on cardiovascular disease in the political guidelines for the 2024-2029 mandate. EACH partners stand ready to support! Together we must and can do better. #CVHealth4All Read more: https://lnkd.in/eBrSQSbh Our EACH Partners: European Society of Cardiology EFPIA - European Federation of Pharmaceutical Industries and Associations COCIR European Atherosclerosis Society European Chronic Disease Alliance ECHDO European Heart Network (EHN) EKHA - European Kidney Health Alliance ERC European Resuscitation Council European Stroke Organisation European Society for Vascular Surgery EUCOPE - European Confederation of Pharmaceutical Entrepreneurs European Institute of Women's Health, CLG ESH European Society of Hypertension European Thrombosis and Haemostasis Alliance FH Europe Foundation MedTech Europe Global Heart Hub Stroke Alliance For Europe (SAFE) World Heart Federation
-